Company
United StatesPublic company, NASDAQ: AMGNAmgen Inc. (NASDAQ: AMGN), New Albany, OH – FDA Inspections
Inspection records and compliance data for Amgen Inc. in New Albany, Ohio. 3 FDA inspections on record, 1 Form 483, last inspected February 04, 2025. Publicly traded as NASDAQ: AMGN.
Company Profile
This profile covers Amgen Inc. based in New Albany, Ohio, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 1
- NAI
- 1
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected November 30, 2023. Last inspected February 4, 2025.
Most cited issue areas
- Reserve drug product sample quantity - all tests1 inspection
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 4, 2025 | Not classified | Human Drugs | 1261008 |
| January 17, 2024 | NAI | Medical Devices & Rad Health · Compliance: Devices | 1228575 |
| November 30, 2023 | VAI | Human Drugs | 1223903 |
FDA documents
Form 483s (1)
EIRs (1)
Other FDA documents (2)
People (4)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Amgen Inc.
Stock ticker
AMGN
Exchange
NASDAQ
Share price
$467.06
Market cap
$252.6B
Price as of
November 13, 2026
FEI Number
3020740318
Address
4150 Ganton Parkway, New Albany, Ohio 43054, United States
Country
United States
ID: f15d2d1c-3482-417a-83de-0efa632c4095